Local Institution

Ravenna 48121

0 studies enrolling now · 8 studies all time

What they study most

Diabetes, Lung Cancer, Lymphoma, Metabolics Diabetes Nos, Multiple Myeloma, Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of the Head and Neck, Unresectable Stage III or IV Malignant Melanoma

Studies at this site

• Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma — Completed
• Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer — Completed
• Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma — Completed
• An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer — Withdrawn before enrolling
• Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010) — Completed
• Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer — Stopped early
• A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise — Completed
• PPAR-COMBO With Sulfonylurea — Completed